Literature DB >> 22503273

Soluble BAFF-R produced by decidual stromal cells plays an inhibitory role in monocytes and macrophages.

B P Deng1, Y Zhang, Q J Wang, X F Xu, H Zhang, Y M Yang, H T Mao, W J Gao, B F Song, B H Kong, X Qu.   

Abstract

A sophisticated immunological regulation between decidual stromal cells (DSC) and monocytes and macrophages is essential for the successful symbiosis of the mother and her fetus, but the mechanisms remain incompletely understood. The mRNA and proteins of B lymphocyte stimulator (BAFF, also known as BLys) and its receptor, BAFF-R (also known as BR3, CD268 or TNFRSF17), have been detected in both first-trimester and term placentas, but whether BAFF or BAFF-R participates in the cross-talk between DSC and monocytes and macrophages in the first-trimester pregnancy has not been described. This study found that purified DSC extensively shed BAFF-R and that polyinosinic:polycytidylic acid (poly(I:C); a synthetic toll-like receptor (TLR) 3 agonist) dramatically up-regulated BAFF-R secretion, suggesting that release of these soluble proteins was an inherent property of DSC and its induction might have relevance to TLR-3-mediated signal transduction. When monocytes were cultured with the supernatants of resting DSC or poly(I:C)-treated DSC, the proliferation of CD14(+)HLA-DR(+) monocytes (P=0.025 and 0.045) and the secretion levels of tumour necrosis factor α (P=0.035 and 0.031) and interleukin 6 (P=0.021 and 0.035) were significantly increased after the BAFF-R was blocked. Soluble BAFF-R may play inhibitory roles in monocytes and macrophages.
Copyright © 2012 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503273     DOI: 10.1016/j.rbmo.2012.02.024

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  2 in total

1.  Analysis of serum B cell-activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus.

Authors:  Fabien B Vincent; Rangi Kandane-Rathnayake; Rachel Koelmeyer; Alberta Y Hoi; James Harris; Fabienne Mackay; Eric F Morand
Journal:  Clin Transl Immunology       Date:  2019-04-21

Review 2.  B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia.

Authors:  Michal Rihacek; Julie Bienertova-Vasku; Dalibor Valik; Jaroslav Sterba; Katerina Pilatova; Lenka Zdrazilova-Dubska
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.